Interventional Neuroradiology, Queens Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Radiological Sciences, Mental Health & Clinical Neuroscience, University of Nottingham, Nottingham, UK.
Eur Stroke J. 2023 Jun;8(2):581-590. doi: 10.1177/23969873231166194. Epub 2023 Mar 30.
Observational studies have demonstrated improved outcomes with the adjunctive use of balloon guide catheters (BGC) during endovascular thrombectomy (EVT) for anterior circulation acute ischaemic stroke (AIS). However, the lack of high-level evidence and global practice heterogeneity justifies a randomised controlled trial (RCT) to investigate the effect of transient proximal blood flow arrest on the procedural and clinical outcomes of patients with AIS following EVT.
Proximal blood flow arrest in the cervical internal carotid artery during EVT for proximal large vessel occlusion is superior to no flow arrest in achieving complete vessel recanalisation.
ProFATE is an investigator-initiated, pragmatic, multicentre RCT with blinding of participants and outcome assessment. An estimated 124 participants with an anterior circulation AIS due to large vessel occlusion, an NIHSS of ⩾2, ASPECTS ⩾ 5 and eligible for EVT using a first-line combined technique (contact aspiration and stent retriever) or contact aspiration only will be randomised (1:1) to receive BGC balloon inflation or no inflation during EVT.
The primary outcome is the proportion of patients achieving near-complete/complete vessel recanalisation (eTICI 2c-3) at the end of the EVT procedure. Secondary outcomes include the functional outcome (modified Rankin Scale at 90 days), new or distal vascular territory clot embolisation rate, near-complete/complete recanalisation after the first pass, symptomatic intracranial haemorrhage, procedure-related complications and death at 90 days.
This is the first RCT to investigate the effect of proximal blood flow arrest during EVT using a BGC on the procedural and clinical outcomes of patients with AIS due to large vessel occlusion.
观察性研究表明,在血管内血栓切除术(EVT)治疗前循环急性缺血性卒中(AIS)时,辅助使用球囊引导导管(BGC)可改善预后。然而,由于缺乏高级别的证据和全球实践的异质性,有必要进行一项随机对照试验(RCT),以研究在 EVT 治疗后 AIS 患者中短暂性近端血流阻断对程序和临床结局的影响。
在 EVT 治疗近端大血管闭塞时,颈内动脉近端血流阻断优于无血流阻断,可实现完全血管再通。
ProFATE 是一项由研究者发起的、实用的、多中心 RCT,对参与者和结局评估进行盲法。预计将有 124 名前循环 AIS 患者因大血管闭塞、NIHSS ⩾2、ASPECTS ⩾5 且适合使用一线联合技术(接触抽吸和支架取栓器)或仅接触抽吸进行 EVT 而入选,将被随机(1:1)分配到在 EVT 期间接受 BGC 球囊充气或不充气。
主要结局是 EVT 结束时达到接近完全/完全血管再通(eTICI 2c-3)的患者比例。次要结局包括功能结局(90 天时改良 Rankin 量表)、新的或远端血管区域血栓栓塞率、首次通过后的接近完全/完全再通、症状性颅内出血、与操作相关的并发症和 90 天时的死亡。
这是第一项研究使用 BGC 在 EVT 期间进行近端血流阻断对 AIS 患者程序和临床结局影响的 RCT。